会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 5. 发明申请
    • CRYSTALLINE FORM OF CHLOROGENIC ACID AND PREPARATION METHOD THEREOF
    • 氯仿的结晶形式及其制备方法
    • US20170050915A1
    • 2017-02-23
    • US15308034
    • 2014-05-16
    • SICHUAN JIUZHANG BIOLOGICAL SCIENCE AND TECHNOLOGY CO., LTD.
    • Jie ZHANGLiang ZHANGWang HUANG
    • C07C69/618C07C67/52
    • C07C69/618C07B2200/13C07C67/52C07C69/732C07C2601/14
    • Provided is a crystalline form of chlorogenic acid. The crystalline form is an orthorhombic crystal system, the space group is P212121, the cell parameters are a=7.7291 (2) Å, b=10.9808 (2) Å, and c=3.5334 (7) Å, α=β=γ=90.00°, Z=8, and the cell volume is 3100.65 (11) Å3. Also provided is a preparation method for the crystalline form. The present crystalline form has good stability and does not significantly change during storage for 48 months in a cool, dark place, and the various indices all meet the relevant requirements for active pharmaceutical ingredients. The crystallisation process provided by the present invention can not only use raw materials having different purities to prepare the same crystalline form of chlorogenic acid, but can also significantly reduce solvent residue in the raw materials, thereby improving product safety.
    • 提供绿原酸的结晶形式。 结晶形式为斜方晶系,空间群为P212121,电池参数为a = 7.7291(2)Å,b = 10.9808(2)Å,c = 3.5334(7),α=β=γ= 90.00°,Z = 8,细胞体积为3100.65(11)Å3。 还提供了结晶形式的制备方法。 目前的结晶形式具有良好的稳定性,在阴凉,黑暗的地方储存48个月时并不显着变化,各种指标都符合活性药物成分的相关要求。 本发明提供的结晶方法不仅可以使用具有不同纯度的原料制备相同的绿原酸结晶形式,而且可以显着降低原料中的溶剂残留量,从而提高产品的安全性。